Comments: Absolute cardiovascular risk assessment for guiding antihypertensive prescribing in Australian primary care patients with hypertension

J Hum Hypertens. 2023 Jun;37(6):426-427. doi: 10.1038/s41371-022-00719-4. Epub 2022 Jul 6.

Authors

Woldesellassie M Bezabhe¹, Gregory M Peterson²

Affiliations

¹ School of Pharmacy and Pharmacology, University of Tasmania, Private Bag 26, Hobart, TAS, 7001, Australia. woldesellassie.bezabhe@utas.edu.au.
² School of Pharmacy and Pharmacology, University of Tasmania, Private Bag 26, Hobart, TAS, 7001, Australia.

No abstract available

MeSH terms

Antihypertensive Agents / adverse effects
Australia / epidemiology
Cardiovascular Diseases* / drug therapy
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / prevention & control
Heart Disease Risk Factors
Humans
Hypertension* / diagnosis
Hypertension* / drug therapy
Hypertension* / epidemiology
Primary Health Care
Risk Assessment
Risk Factors

Substances

Antihypertensive Agents

Supplementary concepts

Australians